We would love for you to become a part of our community. Join our Discord to connect with us and other members!

Ticker
DSFIR.AS

Price
97.72
Stock movement up
+0.96 (0.99%)
Company name
DSM-Firmenich AG
Exchange
(AS
,
Currency
EUR
)
Sector
Basic Materials >
Specialty Chemicals
Markedsværdi
25.92B
Ent værdi
34.67B
Pris/omsætning
2.02
Pris/bog
1.12
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
27.47%
Efterfølgende P/E
-
Fremtidig P/E
32.25
PEG
-
EPS-vekst
-
1 års afkast
11.44%
3 års afkast
-
5 års afkast
-
10 års afkast
-
Senest opdateret: 2025-01-02

UDBYTTE

DSFIR.AS betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E-
Pris til OCF18.29
Pris til FCF45.36
Pris til EBITDA64.73
EV i forhold til EBITDA86.56

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning2.02
Pris til egenkapital1.12
EV i forhold til salg2.70

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier265.28M
EPS (TTM)-3.25
FCF pr. aktie (TTM)2.15

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)12.86B
Bruttofortjeneste (TTM)3.57B
Driftsindkomst (TTM)-427.50M
Nettoindkomst (TTM)-865.00M
EPS (TTM)-3.25
EPS (1 år frem)3.03

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)27.76%
Driftsmargin (TTM)-3.32%
Fortjenstmargin (TTM)-6.73%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter2.46B
Nettotilgodehavender2.55B
Omsætningsaktiver i alt8.84B
Goodwill11.29B
Immaterielle aktiver7.45B
Ejendomme, anlæg og udstyr0.00
Sum aktiver34.27B
Kreditor2.07B
Kortfristet/nuværende langsigtet gæld4.83B
Summen af kortfristede forpligtelser4.52B
Sum gæld11.20B
Aktionærernes egenkapital23.07B
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)1.42B
Investeringsudgifter (TTM)846.00M
Fri pengestrøm (TTM)571.50M
Udbetalt udbytte (TTM)157.00M

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast-3.75%
Afkast af aktiver-2.52%
Afkast af investeret kapital-3.64%
Kontant afkast af investeret kapital2.40%

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning96.22
Daglig høj97.72
Daglig lav96.08
Daglig volumen95K
Højeste gennem alle tider123.65
1 års analytiker estimat132.20
Beta-
EPS (TTM)-3.25
Udbytte pr. aktie-
Ex-div dato9 May 2024
Næste dato for resultatpræsentation13 Feb 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
DSFIR.ASS&P500
Nuværende prisfald fra top notering-20.97%-3.58%
Højeste prisfald-36.94%-56.47%
Højeste efterår dato24 Oct 20239 Mar 2009
Gennemsnitlig fald fra toppen-16.91%-11.12%
Gennemsnitlig tid til nyt højdepunkt109 days12 days
Maks. tid til nyt højdepunkt346 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
DSFIR.AS (DSM-Firmenich AG) company logo
Markedsværdi
25.92B
Markedsværdi kategori
Large-cap
Beskrivelse
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, cultures, hydrocolloids, proteins, natural colorants, nutritional ingredients, premixes and yeast extracts solutions. The Animal Nutrition & Health segment offers animal proteins, as well as vitamins, performance solutions, and data-driven precision services for the animal production industry. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, biomedical materials, and nutrition improvement markets. This segment offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise services, and customized solutions. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
Personale
27926
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Netherlands
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Key Insights DSM-Firmenich's estimated fair value is €115 based on 2 Stage Free Cash Flow to Equity Current share price...
11. november 2024
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.comNEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor confer...
26. september 2024
Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual eventMAASTRICHT, The Netherlands, Sept. 23, 2024 (GLOBE NEWSWIRE) -- dsm-firmenich...
23. september 2024
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday, September 24 and Wednesday, Septembe...
19. september 2024
Key Insights DSM-Firmenich's significant retail investors ownership suggests that the key decisions are influenced by...
12. august 2024
Key Insights DSM-Firmenich's estimated fair value is €119 based on 2 Stage Free Cash Flow to Equity With €101 share...
4. juni 2024
NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced DSM Firmenich AG ...
4. april 2024
Key Insights Significant control over DSM-Firmenich by retail investors implies that the general public has more power...
4. marts 2024